BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35715440)

  • 1. Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study.
    Kang MJ; Lim J; Han SS; Park HM; Kim SW; Lee WJ; Woo SM; Kim TH; Won YJ; Park SJ
    Sci Rep; 2022 Jun; 12(1):10206. PubMed ID: 35715440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
    Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
    J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
    Cho KM; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    Oncologist; 2015 Aug; 20(8):926-33. PubMed ID: 26099746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the incidence and management of biliary tract cancer: a French population-based study.
    Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
    J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan.
    Miyakawa S; Ishihara S; Horiguchi A; Takada T; Miyazaki M; Nagakawa T
    J Hepatobiliary Pancreat Surg; 2009; 16(1):1-7. PubMed ID: 19110652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.
    Zhang D; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Greif PA; Ziemann F; Beyer G; Roessler D; Goni E; Renz B; D'Haese JG; Kunz WG; Seidensticker M; Corradini S; Niyazi M; Ormanns S; Kumbrink J; Jung A; Mock A; Rudelius M; Klauschen F; Werner J; Mayerle J; von Bergwelt-Baildon M; Boeck S; Heinemann V; Westphalen CB
    Target Oncol; 2023 Sep; 18(5):767-776. PubMed ID: 37594677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction model for survival in patients with biliary tract cancer: a development and validation study].
    Han L; Cui P; Tang MS; Zhang M; Cui HJ; Zeng ZQ; Chen SY; Liu SS; Song B; Gu DQ; Wang X; Zhang B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1461-1469. PubMed ID: 31838822
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
    Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
    BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.
    Liao SF; Koshiol J; Huang YH; Jackson SS; Huang YH; Chan C; Huang C; Liu PC; Chen YJ; Hsieh RJ; Huang CP; Lu SN; Chen CJ; Shen CY; Lee MH
    Hepatology; 2021 Oct; 74(4):1994-2006. PubMed ID: 33942350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
    Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
    Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
    Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
    J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative endoscopic cholangiography and biliary drainage in Ampulla of Vater cancer.
    Ahn KS; Kang KJ; Kim YH; Lee YS; Cho GB; Kim TS; Lee JW
    Surg Oncol; 2018 Mar; 27(1):82-87. PubMed ID: 29549909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project.
    Van Dyke AL; Langhamer MS; Zhu B; Pfeiffer RM; Albanes D; Andreotti G; Beane Freeman LE; Chan AT; Freedman ND; Gapstur SM; Giles GG; Grodstein F; Liao LM; Luo J; Milne RL; Monroe KR; Neuhouser ML; Poynter JN; Purdue MP; Robien K; Schairer C; Sinha R; Weinstein S; Zhang X; Petrick JL; McGlynn KA; Campbell PT; Koshiol J
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):348-351. PubMed ID: 29339358
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors in gallbladder and biliary tract cancer.
    Gómez-Roel X; Arrieta O; León-Rodríguez E
    Med Oncol; 2007; 24(1):77-83. PubMed ID: 17673815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biliary tract cancers : Molecular characterization and identification of novel prognostic markers].
    Goeppert B
    Pathologe; 2017 Nov; 38(Suppl 2):192-197. PubMed ID: 29063951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study.
    Lee KJ; Cho JH; Lee SH; Lee KH; Park BK; Lee JK; Woo SM; Ryu JK; Lee JK; Kim YS; Kim JW; Lee WJ
    Scand J Gastroenterol; 2017 Apr; 52(4):437-441. PubMed ID: 27924650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
    Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
    World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.